PATENT CLAIM ANALYSIS

Application Number: 15769113
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "243000"]

Abstract:
PRODRUGS OF IMIDAZOTRIAZINE COMPOUNDS AS CK2 INHIBITORS The invention provides pharmaceutically active compounds of formula (I) and prodrugs thereof. The formula (I) 2-(aminophenylamino)-4-amino-7-cyano-imidazo[2,1-f][1,2,4]triazine derivatives inhibit CK2 protein kinase activity, thereby making them useful for treating cancer, psoriasis and rheumatoid arthritis.

Claim (Index 6):
The compound of  claim 1  having the structure or a stereoisomer, a tautomer, a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.28261
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13940619', '14532218', '14414152', '14191861', '12575589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8283011993175942
- 35 USC 102 Novelty (BERT): 0.5443328562163903
- Combined Prediction Score: 0.7999043650074739
- Mean Citation Score: 394.033546
- Max Citation Score: 415.17645
- Similarity Product: 263.001181890884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test